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Abstract
Cdr1p, a multidrug transporter from a pathogenic yeast Candida albicans, confers resistance to several unrelated drugs
including anti-Candida drugs. We demonstrate that Cdr1p can specifically transport human steroid hormones namely L-
estradiol and corticosterone. Saccharomyces cerevisiae transformant S-12, harbouring the CDR1 gene, accumulated about 3-
fold less [3H]L-estradiol and about 2-fold less [3H]corticosterone than the non-transformed strain. When CDR1 was expressed
in AD strain (AD-CDR1) which had seven ATP binding cassette (ABC) superfamily of putative transporter genes disrupted,
the net accumulation of these hormones as compared to S-12 was significantly lower. Efflux of L-estradiol and corticosterone
was inhibited by a 100-fold higher (200 nM) concentration of L-estradiol, corticosterone, ergosterol or dexamethasone, but
progesterone which could not be transported by Cdr1p did not affect the efflux and thus accumulation. Interestingly, some of
the drugs viz. cycloheximide, chloramphenicol, fluconazole and o-phenanthroline, to which CDR1 confers resistance, could
also prevent efflux and enhance accumulation to some extent. In conclusion, we show that human steroid hormones could be
the substrates for Cdr1p and the energy dependent transport mediated by it is specific for estradiol and corticosterone.
ß 1998 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Multidrug resistance (MDR), where cells exhibit
simultaneous resistance to multiple chemically unre-
lated chemotherapeutic agents, has been one of the
principal causes of failure of chemotherapy [1^3].
The elucidation of the mechanism by which cells
develop resistance to toxic e¡ects of potent chemo-
therapeutic agents has revealed a great deal about
the process of drug uptake, metabolism and extru-
sion. Overexpression of a 170 kDa glycoprotein (P-
glycoprotein) was shown to be responsible for this
phenomenon in mammals including humans [1^3].
Such MDR proteins are widely distributed through-
out the evolutionary scale [4^6]. Yeast is no excep-
tion, in fact more than two dozen loci responsible for
pleiotropic drug resistance (PDR) have been identi-
¢ed mostly in Saccharomyces cerevisiae and a few in
Schizosaccharomyces pombe [7,8]. The class of trans-
0378-1097 / 98 / $19.00 ß 1998 Published by Elsevier Science B.V. All rights reserved.
PII S 0 3 7 8 - 1 0 9 7 ( 9 7 ) 0 0 5 0 2 - 8
FEMSLE 7930 5-1-98
* Corresponding author. Fax: +11 (91) 6198234, 6165886;
E-mail: rajendra@jnuniv.ernet.in
FEMS Microbiology Letters 158 (1998) 69^74
porters in yeasts not only includes ATP binding cas-
sette (ABC) family of transporters and multidrug
resistance-associated protein family (MRP) of trans-
porters but also a family of membrane facilitators
(MFS), which are basically symporters [9]. In addi-
tion, regulatory networks of PDR, genes backed by
transcription regulators, are also very well character-
ised [7,9].
The studies involving MDR in yeast have at-
tracted much attention, since some of the species
are also pathogenic to humans. Candida albicans is
a dimorphic, opportunistic human pathogen, which
is naturally more resistant to several drugs than S.
cerevisiae [6]. In recent years, the incidence of C.
albicans cells acquiring resistance to azoles and poly-
enes has increased considerably [6,10,11]. In this re-
gard, the cloning and sequencing of a multidrug
transporter, CDR1 (Candida drug resistance) in C.
albicans, which is a homologue of S. cerevisiae multi-
drug e¥ux pump PDR5 [7,9], was an important step
towards an understanding of the mechanism of drug
resistance [12]. A few more homologues of CDR1
have been identi¢ed recently in C. albicans [13,14]
and few genes speci¢c to £uconazole and benomyl
resistance have also been characterised [6,8,15,16].
The knowledge of physiological substrates and role
of MDRs continue to be elusive. Except for human
MDR1, which is a general phospholipid translocator
and steroid transporter [17,18] and MDR2, which is
a speci¢c phosphatidylcholine translocator, between
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Fig. 1. Time course of L-estradiol transport. a: L-estradiol transport in host strain JG436, a PDR5 disruptant. Cells (yeast transformants)
from mid-log phase were centrifuged and washed twice at 500Ug and resuspended in fresh YNB medium as 10% cell suspension. 1.5 ml
of cell suspension was incubated for 5 min in shaking water bath at 150 rpm at 30‡C. The reaction was started by the addition of 2 nM
of [3H]L-estradiol (91 Ci/mmol) or corticosterone (81 Ci/mmol). An aliquot of cells was withdrawn at indicated time intervals, ¢ltered rap-
idly and washed thrice with 10 mM PBS, pH 7.4, containing 2% glucose, on Millipore manifold ¢ltration assembly using 0.45 Wm cellu-
lose nitrate ¢lter (Millipore, USA). Control experiments, without cells, were also performed and the background count on the ¢lters which
were always less than 10%, were deducted from the ¢nal values. b: L-estradiol transport in S12. c: L-estradiol transport in strain
AD1234568 (AD). d: L-estradiol transport in transformant of AD (AD-CDR1). The transport was carried out as described in a. The bar
in each ¢gure shows standard deviation and values are the mean of three independent experiments.
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lipid monolayers [19], none of the characterised
genes is so distinctly identi¢ed with its functions.
Yeast MDRs are no exception and from host of
genes identi¢ed as putative e¥ux pumps, none could
be related with their physiological roles, the only
exception being STE6, of S. cerevisiae [7,9]. STE6
codes for an ABC protein and is known to export
mating factor in yeast [20]. The fact that S. cerevisiae
having disrupted SNQ2 and PDR5, shows higher
accumulation of estradiol as compared to their pa-
rental strain, suggests that steroids could be physio-
logical substrates for these ABC pumps [21,22].
Though Cdr1p is a homologue of PDR5p and
SNQ2p, it has di¡erent pro¢le of drug resistance
and regulation of its activity. PDR1 and PDR3,
which are well known transcription factors which
regulate PDR5 expression, do not have homologous
binding domains in CDR1 promoter [9,12]. In addi-
tion, CDR1 promoter has regulatory elements which
are not found in PDR5 promoter. In view of above
facts and considering the sites of infection of C. al-
bicans in humans, it was most appropriate to ascer-
tain if this pathogenic yeast has also adapted to
transport steroids. This communication, for the ¢rst
time, describes in detail the speci¢city of an energy
dependent steroid transport, mediated by Cdr1p, in a
background where seven ABC transporters are de-
leted. We also demonstrate that drugs, which are
e¥uxed out by Cdr1p, competitively inhibit steroid
accumulation.
2. Materials and methods
2.1. Strains and growth media
S. cerevisiae JG436 (Mat a, PDR5 : :Tn5, leu2,
met5, ura3-52, mak71, KRB1) [12] was a kind gift
from Dr. J. Golin, Catholic University of America,
Washington, DC, USA. S. cerevisiae AD 1234568
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Fig. 2. Kinetics of corticosterone transport in host and transformed yeast, harbouring the CDR1 gene. a: Corticosterone transport in host
strain JG436. b: Corticosterone transport in S-12. c: Corticosterone transport in AD1234568 (AD). d: Corticosterone transport in trans-
formant of AD (AD-CDR1). The transport of corticosterone was carried out as described in Fig. 1a. The bar in each ¢gure shows stand-
ard deviation and values are the mean of three independent experiments.
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(Mat K, pdr1-3, his, ura3, pdr5v, snq2v, pdr10v,
pdr11v, pdr15v, yor1v, ycf1v), was a kind gift
from A. Go¡eau and A. Decottignies, UniversiteŁ
Catholique de Louvain, Belgium. Both the strains
were transformed with the CDR1 gene by a method
described earlier [12] and the resulting transformants
harbouring CDR1 were designated S-12 and AD-
CDR1.
2.2. Transport of [3H]L-estradiol and corticosterone
The accumulation of steroid hormone [3H]L-estra-
diol and [3H]corticosterone was determined by the
modi¢ed method described elsewhere [21]. The re-
sults presented show net accumulation of steroids
at the indicated time and not the e¥ux.
3. Results and discussion
3.1. Transport of L-estradiol and corticosterone is
mediated by Cdr1p
S. cerevisiae strain JG436, hypersensitive to cyclo-
heximide due to disrupted PDR5, was used as a host
to express CDR1 of C. albicans. The resulting strain
S-12, hyper-resistant to cycloheximide and other
drugs [12], was used to check whether Cdr1p could
transport human steroid hormones. It is pertinent to
mention here that steroids, which are small hydro-
phobic molecules, enter S. cerevisiae cells by di¡u-
sion [21]. The strain JG436 showed steady accumu-
lation of [3H]L-estradiol (Fig. 1a). However, due to
continuous e¥ux of these substrates mediated by
Cdr1p, strain S-12 showed much less accumulation
(at 60 min JG436 had 19 pmoles/mg dry weight of
[3H]L-estradiol while it was 7.0 pmoles/mg dry
weight in S-12) (Fig. 1a and b). Similarly,
[3H]corticosterone was rapidly e¥uxed out from S-
12 cells (at 60 min JG436 had 6.5 pmoles of
[3H]corticosterone, while it was 3 pmoles per mg
dry weight in S-12 cells) (Fig. 2a and b).
Although JG436 does not have a functional Pdr5,
it is known to harbour several other putative e¥ux
pumps, which might still mask the function of Cdr1p
[23]. We therefore used a S. cerevisiae strain
AD1234568 (called as AD hereafter in this paper)
constructed by A. Decottignies, in A. Go¡eau’s
group, where in seven ABC transporter genes, e.g.
PDR5, PDR10, PDR11, PDR15, SNQ2 (Saccharo-
myces nitroquinoline oxide resistance gene), YCF1
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Fig. 3. Speci¢city of L-estradiol e¥ux mediated by CDR1. a:
Competition of L-estradiol transport in AD-CDR1 cells, by ster-
oids and drugs. Transport was carried out in the presence of
100-fold (200 nM) cold steroids or drugs. W/o, without competi-
tor; Erg, ergosterol ; Dex, dexamethasone; Est, L-estradiol ; Cyh,
cycloheximide; Chl, chloramphenicol ; Flu, £uconazole; Chol,
cholesterol ; Cort, corticosterone; Phe, phenanthroline; Rh123,
rhodamine123; Vin, vinblastine; and Prog, progesterone. b: In-
hibition of L-estradiol e¥ux by di¡erent inhibitors. The cells
were exposed to indicated concentrations of inhibitors, sodium
azide (10 mM); CCCP, carbonyl cyanide m-chlorophenylhydra-
zone (100 WM); KCN, potassium cyanide (1 Wg/ml) ; Van, sodium
orthovanadate (100 WM) and Val, valinomycin (200 nM), 10 min
before the commencement of the transport and the transport was
carried out as described in the legend of Fig. 1a. The bar in each
¢gure shows standard deviation and values are the mean of three
independent experiments.
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(yeast cadmium factor gene) and YOR1 (yeast oligo-
mycin resistance gene) were disrupted. So all the fol-
lowing transport experiments have been done with
strain AD harbouring CDR1 called as AD-CDR1.
Interestingly, when transport of [3H]L-estradiol and
[3H]corticosterone was studied in AD-CDR1, the re-
sults were more dramatic. As can be seen from Fig.
1c and d, the AD strain showed higher accumulation
of [3H]L-estradiol (50 pmoles/mg dry weight), the
uptake could never reach above 20 pmoles/mg dry
weight in AD-CDR1 and at 60 min it was less than
10 pmoles/mg dry weight. Similar was the case with
[3H]corticosterone, where the accumulation was
much less in AD-CDR1 (Fig. 2c and d). It is impor-
tant to point out here that none of these transform-
ants was able to show the e¥ux of [3H]progesterone,
suggesting that progesterone may not be a substrate
of Cdr1p (data not shown). Although both S-12 and
AD-CDR1 showed reduced accumulation as com-
pared to their host lacking CDR1 gene, the di¡erence
in accumulation levels was very signi¢cant in AD-
CDR1. The deletion of seven ABC type transporters
in AD-CDR1 ensured unmasked functioning of
Cdr1p. A range of [3H]estradiol concentrations (0.1
to 10 nM) was used to determine the Km of estradiol
accumulation. Total accumulation of estradiol was
measured at each concentration up to 1 h. The re-
sulting accumulation was plotted (Linweaver-Burk
plot), to obtain Km values, using Sigma plot (Jandel
Scienti¢c),. However, the Km values, which were in
the range of 0.5^1.0 nM (data not shown), do not
directly re£ect the a⁄nity of estradiol.
3.2. L-estradiol and corticosterone transport mediated
by Cdr1p is speci¢c
Cdr1p is known to e¥ux many unrelated hydro-
phobic xenobiotics and as a result it is able to confer
resistance to a variety of drugs [12]. The transport of
steroid hormones by Cdr1p provided an opportunity
to check in vivo speci¢city of this pump. AD-CDR1
cells were exposed to a 100-fold higher concentration
of other steroid hormones (200 nM) before assaying
for [3H]L-estradiol accumulation. An excess concen-
tration (100-fold) of L-estradiol, corticosterone, dex-
amethasone, cholesterol and ergosterol prevented ef-
£ux of labeled substrate and led to increased
accumulation (Fig. 3a). Progesterone, on the other
hand, had no e¡ect on the transport of either of
the steroids. Several drugs, e.g. cycloheximide, o-phe-
nanthroline, chloramphenicol, £uconazole and rhod-
amine 123, which are expected to be e¥uxed by
Cdr1p were also able to a¡ect the exit of both the
hormones (Fig. 3a). The transport of corticosterone
also showed similar speci¢cities (data not shown).
3.3. Transport of L-estradiol and corticosterone is
energy dependent
Cdr1p has been shown to contain adenosine tri-
phosphatase (ATPase) and uridine triphosphatase
(UTPase) activities, which have features very distinct
from plasma membrane ATPase (PM-ATPase), e.g.
broad substrate speci¢cities and pH optima (Krish-
namurthy et al., unpublished results). The external
pH did not signi¢cantly a¡ect the ability to transport
these hormones, which correlates well with the
broader pH optimum of nucleotide triphosphatase
activity of Cdr1p (data not shown). The e¥ux of
L-estradiol was inhibited by sodium azide as well
as by other inhibitor of energy metabolism, carbonyl
cyanide m-chlorophenylhydrazone (CCCP). Other
inhibitors such as sodium orthovanadate (ATPase
inhibitor), potassium cyanide (KCN) and valinomy-
cin (ionophore) also prevented the exit of L-estradiol
(Fig. 3b), albeit to a lesser extent. Transport of cor-
ticosterone showed similar results indicating that it is
also energy dependent (data not shown).
In conclusion, our results demonstrate that Cdr1p,
a multidrug transporter, can selectively mediate en-
ergy dependent transport of human steroid hor-
mones with high a⁄nity and speci¢city. It is possible
that these hormones might be physiological sub-
strates of Cdr1p. In this regard, it is pertinent to
mention that corticosteroid and estrogen binding
proteins in C. albicans and other species of Candida
have been identi¢ed and related to its pathogenicity
[24]. The interaction of some of the azoles such as
ketoconazole, with the corticosteroid receptor and
binding protein has been suggested [25]. Moreover,
the presence of a steroid response element in the
promoter of CDR1 (unpublished results) and the up-
regulation of CDR1 transcription by L-estradiol,
strongly suggest a possibility of a steroid receptor
cascade, linked to multidrug resistance in C. albicans
(Krishnamurthy et al., submitted for publication).
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The steroid e¥ux system mediated by Cdr1p, could
also be a part of the total sterol homeostasis of Can-
dida cells. Studies are underway in our laboratory to
con¢rm the above hypothesis.
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